Table 4 Procedural characteristics of the studied population
Group 1 (n=112) | Group 2 (n=388) | p value | |||
|---|---|---|---|---|---|
Number of diseased vessels | |||||
One vessel CAD | 32 | 28.6% | 160 | 41.2% | X2p=0.218 |
Two vessel CAD | 52 | 46.4% | 154 | 39.7% | |
Three vessel CAD | 28 | 25% | 74 | 19.1% | |
Culprit vessel | |||||
LAD | 24 | 21.4% | 206 | 53.1% | X2p=<0.001 |
LCX | 62 | 55.4% | 154 | 25.8% | |
RCA | 26 | 23.2% | 74 | 21.1% | |
Site of the lesion | |||||
Proximal | 28 | 50% | 95 | 48.9% | X2p=0.23 |
Mid | 20 | 35.7% | 74 | 37.2% | |
Distal | 8 | 14.3% | 25 | 13.9% | |
TIMI pre procedure | |||||
0 | 112 | 100% | 0 | 0 % | X2p =<0.001 |
I | 0 | 0% | 0 | 0 % | |
II | 0 | 0% | 64 | 16.5% | |
III | 0 | 0% | 324 | 83.5% | |
Use of GP IIa–IIIb antagonists | 26 | 23% | 14 | 3 | p=0.04 |
Collaterals | 82 | 73.2% | 18 | 4.6% | X2p =<0.01 |
TIMI III post procedure | 110 | 98.2% | 384 | 98.9% | p=0.36 |
Syntax score | |||||
Mean ± SD | 11.68 ± 6.05 | 6.79 ± 3.24 | MWp =0.12 | ||
Median | 10 | 7.0 | |||
Min–Max | 4.0–24.0 | 4.0–22.0 | |||
Residual syntax score | |||||
Mean ± SD | 1.27 ± 2.67 | 0.66 ± 2.35 | MWp=0.07 | ||
Median | 0 | 0 | |||
Min–Max | 0–15 | 0–20 | |||